Brunton LL, Chabner BA, Knollmann BC. (Eds.). (2011). Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 12 ed. Chapter 22, Treatment of Central Nervous System Degenerative Disorders. New York: McGraw-Hill.
Cook NP, Kilpatrick K, Segatori L, Mart AA. (2012). Detection of α-synuclein amyloidogenic aggregates in vitro and in cells using light-switching dipyridophenazine ruthenium(ii) complexes. Journal of the American Chemical Society 121214074651005 doi:10.1021/ja3100287.
Cummings JL, Henchcliffe C, Schaier S, et al. (2011). The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration. Brain 134(Pt 11):3146–66. doi: 10.1093/brain/awr177. Epub 2011 Aug 2.
Food and Drug Administration (FDA). (2010). Coping with memory loss. Retrieved October 18, 2012 from http://www.fda.gov/downloads/ForConsumers/
ConsumerUpdates/UCM197079.pdf.
Hoehn M, Yahr M . (1967). Parkinsonism: Onset, progression and mortality. Neurology 17(5): 427–42. PMID 6067254.
Huot P, Johnston TH, Koprich JB, et al. (2013). The pharmacology of L-DOPA-induced dyskinesia in Parkinson’s disease. Pharmacol Rev 10;65(1):171–222. doi:10.1124/pr.111.005678.
Kalda A, Yu L, Oztas E, Chen JF. (2006). Novel neuroprotection by caffeine and adenosine A(2A) receptor antagonists in animal models of Parkinson’s disease. J Neurol Sci 248(1-2):9–15.
Kumar KR, Djarmati-Westenberger A, Grünewald A. (2011). Genetics of Parkinson’s disease. Semin Neurol 31(5):433–40. doi: 10.1055/s-0031-1299782. Epub 2012 Jan 21.
Martinez TN, Greenamyre JT. (2012). Toxin models of mitochondrial dysfunction in Parkinson’s disease. Antioxid Redox Signal 16(9):920–34. doi: 10.1089/ars.2011.4033. Epub 2011 Jul 12.
Medline Plus.(2012). Parkinson’s Disease. Retrieved July 29, 2012 from http://www.nlm.nih.gov/medlineplus/parkinsonsdisease.html.
National Institutes of Health (NIH). (2012). Senior Health. Retrieved December 12, 2012 from http://nihseniorhealth.gov/parkinsonsdisease/
surgicaltreatmentsandothertherapies/01.html.
National Institute of Neurological Disorders and Stroke (NINDS). (2012.) Parkinson’s Disease Information Page. Retrieved August 8, 2012 from http://www.ninds.nih.gov/disorders/parkinsons_disease/parkinsons_disease.htm.
Okun MS. (2012). Deep-brain stimulation for Parkinson’s disease. N Engl J Med 367(16):1529–38. doi:10.1056/NEJMct1208070.
Wikipedia. (2012a, August 3). Parkinson’s Disease. Wikimedia Foundation. Retrieved August 3, 2012 from http://en.wikipedia.org/wiki/Parkinson%27s_disease#cite_note-pmid21419704-98.
Wikipedia. (2012b, August 3). History of Parkinson’s Disease. Wikimedia Foundation. Retrieved August 3, 2012 from http://en.wikipedia.org/wiki/History_of_Parkinson%27s_disease.